menu

Unmet needs in lowering LDL-c

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Role of CETP inhibitors in cardiovascular risk reduction - Will lessons from the past lead to future success?

Unmet needs in lowering LDL-c

MinuteCE®
Unmet needs in lowering LDLc
Restart
Resume

Subtitles available:  English, German, French & more

Choose a format
Media formats available:
Take 1 Minute Challenge
1 Minute Challenge Completed
0.75 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Episodes
Presenters
Documents
Comments
  • Overview

    There is a need to improve LDL-c goal attainment in patients with high or very high CV risk. Many patients need additional therapies on top of statins to lower residual CV risk. Do CETP inhibitors have the potential to facilitate further CV risk reduction? In this series, three experts discuss the unmet needs in LDL-c lowering, provide novel insights on CETP inhibition, and explain what we have learned from trials with CETP inhibitors.

    This course consists of 3 episodes. Watch all episodes, answer pre- and post-test questions, and start earning CME credits.

  • Learning Objectives

    • Describe the need for novel LDL-c-lowering therapies as part of intensive lipid-lowering strategies
    • Provide possible reasons why inconsistent results with regards to CV outcomes were obtained with various CETP inhibitors
    • Describe the effects of CETP gene variants on clinical outcomes
    • Recall outcomes of clinical trials with a novel CETP inhibitor
  • Target Audience

    This educational activity is designed for all healthcare professionals with an interest in management of patients with hypercholesterolemia.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for .75 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 CME credits. Approval is valid until December 4, 2024. PAs should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    Funding for this educational program was provided by an unrestricted educational grant from NewAmsterdam Pharma.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medcon International. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule25 Jun 2024